Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Letrozole in Locally Advanced Breast Cancer
NCT00237133Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2003
- Primary completion
- Jan 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of letrozole in breast cancer, sponsored by Novartis. Primary endpoint: Safety and tolerability of Letrozole. Started Mar 2003; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00237133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237133.